Emerging Therapies for Neovascular Age-Related Macular Degeneration: State of the Art

Publisher： Karger

E-ISSN： 1423-0267|221|6|366-377

ISSN： 0030-3755

Source： Ophthalmologica, Vol.221, Iss.6, 2007-10, pp. : 366-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neovascular Age-Related Macular Degeneration

Ophthalmologica, Vol. 227, Iss. 1, 2012-04 ,pp. : 11-20

Karger

Access to resources Recommend Favorite

Emerging Pharmacologic Therapies for Wet Age-Related Macular Degeneration

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 401-410

Karger

Access to resources Recommend Favorite

Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration

Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Emerging Therapeutic Options in Age-Related Macular Degeneration

Ophthalmic Research, Vol. 53, Iss. 4, 2015-0 ,pp. : 194-199

Karger

Access to resources Recommend Favorite

Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration

By Patel Ravi D. Momi Rominder S. Hariprasad Seenu M.

Seminars in Ophthalmology, Vol. 26, Iss. 6, 2011-11 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite